World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
54
Citations
20057
World Ranking
3835
National Ranking
1758

S. Louis Bridges publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where S. Louis Bridges sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 174 publications — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

S. Louis Bridges D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where S. Louis Bridges sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 54 D-Index — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

S. Louis Bridges is affiliated with the University of Alabama at Birmingham in the United States. Their research primarily focuses on medicine, with a notable emphasis on rheumatology, immunology, surgery, radiology, nuclear medicine and imaging, and pathology and forensic medicine.

Their work covers several main topics within these fields, including:

  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • T-cell and B-cell Immunology
  • Cytokine Signaling Pathways and Interactions
  • Monoclonal and Polyclonal Antibodies Research
  • Lymphoma Diagnosis and Treatment
  • Immune Cell Function and Interaction

Bridges has contributed frequently to a range of scientific publication venues. Some of the venues where they have published extensively include:

  • UNC Libraries
  • Arthritis & Rheumatology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Genetics
  • Nature Communications

Their recent papers highlight engagement with significant research topics and prestigious journals:

  • "Notch signalling drives synovial fibroblast identity and arthritis pathology," published in Nature in 2020
  • "Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis," published in Nature Genetics in 2022
  • "Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes," published in Nature Genetics in 2021
  • "2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases," published in Arthritis Care & Research in 2023
  • "Why women have more autoimmune diseases than men: An evolutionary perspective," published in Evolutionary Applications in 2020

Bridges frequently collaborates with several co-authors who contribute to similar scientific topics. Among the most frequent collaborators are:

  • Larry W. Moreland
  • Laura B. Hughes
  • Vivian P. Bykerk
  • Andrew Filer
  • V. Michael Holers

This scientist's publication record demonstrates a sustained commitment to advancing understanding in rheumatology and immunology, with a particular focus on autoimmune diseases and related immune functions. Their research encompasses a broad spectrum from genetic analyses and cellular mechanisms to clinical guidelines and evolutionary perspectives on diseases.

Best Publications

  • 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

    Jasvinder A. Singh;Kenneth G. Saag;S. Louis Bridges;Elie A. Akl

  • Genetics of rheumatoid arthritis contributes to biology and drug discovery

    Yukinori Okada;Yukinori Okada;Di Wu;Di Wu;Di Wu;Gosia Trynka;Gosia Trynka;Towfique Raj;Towfique Raj

  • 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

    Jasvinder A. Singh;Daniel E. Furst;Aseem Bharat;Jeffrey R. Curtis

  • American College of Rheumatology 2008 Recommendations for the Use of Nonbiologic and Biologic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis

    Kenneth G. Saag;Gim Gee Teng;Nivedita M. Patkar;Jeremy Anuntiyo

  • 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis: ACR RA Treatment Recommendations

    Jasvinder A. Singh;Kenneth G. Saag;S. Louis Bridges;Elie A. Akl

  • A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial

    Larry W. Moreland;James R. O'Dell;Harold E. Paulus;Jeffrey R. Curtis

  • A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases.

    Damini Jawaheer;Michael F. Seldin;Christopher I. Amos;Wei V. Chen

  • REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis.

    Peter K Gregersen;Chistopher I Amos;Annette T Lee;Yue Lu

  • Screening the genome for rheumatoid arthritis susceptibility genes: A replication study and combined analysis of 512 multicase families

    Damini Jawaheer;Michael F. Seldin;Christopher I. Amos;Wei V. Chen

  • Does gamma-aminobutyric acid (GABA) influence the development of chronic inflammation in rheumatoid arthritis?

    James M Kelley;Laura B Hughes;S Louis Bridges

  • The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept.

    Lindsey A. Criswell;Raymond F. Lum;Kevin N. Turner;Blanche Woehl

  • A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries.

    Jeffrey R. Curtis;Archana Jain;Johan Askling;S. Louis Bridges

  • Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis

    Jing Cui;Eli A. Stahl;Eli A. Stahl;Eli A. Stahl;Saedis Saevarsdottir;Corinne Miceli;Corinne Miceli

  • Vitamin D Status and Its Associations with Disease Activity and Severity in African Americans with Recent-onset Rheumatoid Arthritis

    Steven M. Craig;Fang Yu;Jeffrey R. Curtis;Graciela S. Alarcón

  • Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy.

    Jing Cui;Saedis Saevarsdottir;Brian Thomson;Leonid Padyukov

  • Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial.

    Iris Navarro-Millán;Christina Charles-Schoeman;Shuo Yang;Joan M. Bathon

  • IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation.

    Esther Zumaquero;Sara L Stone;Christopher D Scharer;Scott A Jenks

  • Integration of sequence data from a consanguineous family with genetic data from an outbred population identifies PLB1 as a candidate rheumatoid arthritis risk gene

    Yukinori Okada;Dorothee Diogo;Dorothee Diogo;Jeffrey D. Greenberg;Faten Mouassess

  • Contribution of Vh gene replacement to the primary B cell repertoire.

    Zhixin Zhang;Michael Zemlin;Michael Zemlin;Yui-Hsi Wang;Delicia Munfus

  • Why women have more autoimmune diseases than men: An evolutionary perspective

    Unknown

  • Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis

    Solveig K. Sieberts;Fan Zhu;Javier García-García;Eli Stahl

  • Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes

    C.C. Robertson;J.R.J. Inshaw;S. Onengut-Gumuscu;W.M. Chen

Frequent Co-Authors

Larry W. Moreland
Larry W. Moreland University of Colorado Anschutz Medical Campus
Jeffrey R. Curtis
Jeffrey R. Curtis University of Alabama at Birmingham
Peter K. Gregersen
Peter K. Gregersen Feinstein Institute for Medical Research
Leigh F. Callahan
Leigh F. Callahan University of North Carolina at Chapel Hill
Robert M. Plenge
Robert M. Plenge Bristol Myers Squibb
Lindsey A. Criswell
Lindsey A. Criswell National Institutes of Health
Paul P. Tak
Paul P. Tak GlaxoSmithKline (United Kingdom)
Robert P. Kimberly
Robert P. Kimberly University of Alabama at Birmingham
Eli A. Stahl
Eli A. Stahl Icahn School of Medicine at Mount Sinai
Soumya Raychaudhuri
Soumya Raychaudhuri Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse career paths, especially in healthcare and research. Many students consider advancing their clinical expertise through programs such as acute care certification for FNP, which allows Family Nurse Practitioners to specialize in more critical patient care settings. This certification helps expand opportunities in acute and emergency care environments.

For those looking to fast-track their clinical qualifications, accelerated nurse practitioner programs offer a streamlined route to becoming licensed providers. These online programs combine rigorous coursework with practical training, perfect for career changers or those seeking rapid advancement.

Non-nurses interested in entering the healthcare field can explore online ADN programs for non nurses. These flexible online degrees provide foundational nursing skills, preparing graduates for licensure exams and entry-level positions.

Additionally, the availability of the easiest ABSN programs to get into enables many aspiring nurses to quickly earn a Bachelor of Science in Nursing. These programs emphasize accelerated learning and accessibility, making them a popular choice for career advancement.

Best Scientists Citing S. Louis Bridges

Trending Scientists

Recently Published Articles